Flovent Diskus (fluticasone propionate inhalation powder)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)   July 2016 ADVERSE REACTIONS Postmarketing Experience Infections and Infestations: Esophageal candidiasis. USE...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts